DEL FABRO, VITTORIO
 Distribuzione geografica
Continente #
AS - Asia 175
EU - Europa 124
NA - Nord America 67
SA - Sud America 37
AF - Africa 5
Totale 408
Nazione #
HK - Hong Kong 83
SG - Singapore 75
US - Stati Uniti d'America 65
IT - Italia 37
BR - Brasile 35
FR - Francia 25
DE - Germania 19
IE - Irlanda 17
TR - Turchia 7
GB - Regno Unito 5
NL - Olanda 5
AT - Austria 4
EE - Estonia 2
ES - Italia 2
IL - Israele 2
PL - Polonia 2
SE - Svezia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
CA - Canada 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
FI - Finlandia 1
HR - Croazia 1
IN - India 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 408
Città #
Hong Kong 83
Singapore 30
Florence 20
The Dalles 18
Dublin 17
Frankfurt am Main 8
Düsseldorf 6
Istanbul 5
Rome 5
Santa Clara 5
Assago 4
Bexley 4
Milan 3
Ashburn 2
Catania 2
Lauterbourg 2
Lençóis Paulista 2
New York 2
Newark 2
Nuremberg 2
Rio de Janeiro 2
San Francisco 2
São Paulo 2
Tashkent 2
Wroclaw 2
Adana 1
Alegre 1
Amsterdam 1
Ankara 1
As Sālimīyah 1
Atlanta 1
Baghdad 1
Baku 1
Barcelona 1
Belo Horizonte 1
Belém 1
Betim 1
Bom Jardim de Goiás 1
Boston 1
Brasília 1
Brooklyn 1
Campinas 1
Cape Town 1
Carapicuíba 1
Castelo do Piauí 1
Chapecó 1
Chicago 1
Curitiba 1
Diadema 1
Espera Feliz 1
Guaraciaba do Norte 1
Helsinki 1
Iaciara 1
Itaúna 1
Londrina 1
Los Angeles 1
Malmesbury 1
Mascalucia 1
Mexico City 1
Nairobi 1
Nederland 1
Niterói 1
Orlando 1
Paipa 1
Paracatu 1
Paternò 1
Pavlodar 1
Pedra Azul 1
Piritiba 1
Porto Seguro 1
Portsmouth 1
Recife 1
Rio Branco 1
Rio Grande 1
Roubaix 1
Royse City 1
San Jose 1
Sand Springs 1
Santiago 1
Stockholm 1
São Gotardo 1
São Luís 1
Tanta 1
Tavares 1
Tel Aviv 1
Toronto 1
Tucson 1
Vienna 1
Vientiane 1
Volta Redonda 1
Zagreb 1
Totale 298
Nome #
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 27
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 24
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 23
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 22
Emergencies in Hematology: Why, When and How I Treat? 22
Multiple Myeloma in 2023 Ways: From Trials to Real Life 21
Chemotherapy extravasation: diagnosis, prevention and management 20
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 20
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical Aspects 19
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 18
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 17
Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: A retrospective real-life survey of the sicilian myeloma network 17
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 16
Clinical benefit of long-term disease control with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients 16
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study 15
Lenalidomide and pomalidomide improve function and induce fcγri/cd64 in multiple myeloma neutrophils 15
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 15
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 15
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 15
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 14
Role of serum free light chain assay in relapsed/refractory multiple myeloma. A real‐life unicentric retrospective study 13
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 13
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review 13
Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network 11
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 11
Serum free light chains and multiple myeloma: Is it time to extend their application? 9
Totale 441
Categoria #
all - tutte 2.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025441 0 0 0 7 10 95 31 80 41 79 66 32
Totale 441